Alterations of the P16 gene in uterine cervical carcinoma from Indian patients

International Journal of Gynecological Cancer

Volumn 13, Issue 4, 2003, Pages 472-479

  Tripathi, A ^a   Banerjee, S ^b   Roy A , ^a   Roychowdhury S , ^b   Panda, C K ^a,c  

^a MEDICAL COLLEGE AND HOSPITAL   (India)

^b INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

^c CHITTARANJAN NATIONAL CANCER INSTITUTE   (India)

Author keywords

Allelic alterations (LOH MA); Homozygous deletion; Human papillomavirus (HPV); Hypermethylation; Mutation; P16

Indexed keywords

MICROSATELLITE DNA; PROTEIN P16;

ADULT; ARTICLE; CARCINOGENESIS; CLINICAL ARTICLE; DNA HYPERMETHYLATION; DNA METHYLATION; FEMALE; GENE DELETION; GENE LOCUS; GENE MUTATION; HETEROZYGOSITY LOSS; HOMOZYGOSITY; HOMOZYGOUS DELETION; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN TISSUE; INDIAN; PRIORITY JOURNAL; PROMOTER REGION; TUMOR SUPPRESSOR GENE; UTERINE CERVIX CARCINOMA; VIRUS INFECTION; WART VIRUS;

ADULT; AGED; ALLELES; BASE SEQUENCE; BIOPSY, NEEDLE; CARCINOMA; CHI-SQUARE DISTRIBUTION; DNA, NEOPLASM; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, P16; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMMUNOHISTOCHEMISTRY; INDIA; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTATION; NEOPLASM STAGING; POLYMERASE CHAIN REACTION; PROBABILITY; PROGNOSIS; SAMPLING STUDIES; SENSITIVITY AND SPECIFICITY; UTERINE CERVICAL NEOPLASMS;

EID: 1242294373     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1438.2003.13330.x     Document Type: Article

References (34)

1. Parkin DM, Pasini P, Ferlay J. Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer 1999;54:827-41.
2. Murthy NS, Mathew A. Screening for cancer of the uterine cervix and approaches adopted in India. Indian J Cancer 1999;36:154-62.
3. Sen U, Sankaranarayanan R, Mandal S, Ramanakumar AV, Parkin DM, Siddiqi M. Cancer patterns ineastern India: The first report of the Kolkata cancer registry. Int J Cancer 2002;100:86-91.
4. Ponten J, Adami HO, Bergstrom R et al. Strategies for global control of cervical cancer. Int J Cancer 1995;60:1-26.
5. Franco EL. Epidemiology in the study of cancer. Encyclopedia of cancer 1997;1:621-41.
6. Hausen HZ. Papilloma virus causing cancer: Evasion from host cell control in early events of carcinogenesis. J Natl Cancer Inst 2000;92:690-8.
7. Lazo PA. Molecular genetics of cervical carcinoma. Br J Cancer 1999;80:2008-18.
8. Wang W, Wong YF, Wong FWS, Chang AMZ. Chromosomal alterations in cervical carcinoma. Med Sci Res 1992;20:193-4.
9. Serrano M, Hannon GJ, Beach D. A new regulatory motif in cell cycle control causing specific inhibition of cyclinD/cdk4. Nature 1993;366:704.
10. Shintani S, Nakahara Y, Mihara M, Ueyama Y, Matsumura T. Inactivation of the p14(ARF), p15 (INK4B) and p16 (INK4A) genes is a frequent event in human oral squamous cell carcinoma. Oral Oncol 2001;37:498-504.
11. Kim JR, Kim SY, Kim MJ, Kim JH. Alterations of CDKN2(MTS1/p16INK4A) gene in paraffin-embedded tumor tissues of human stomach, lung, cervix and liver cancers. Exp Mol Med 1998;30:109-14.
12. Munirajan AK, Kannan K, Bhuvarahamurthy V et al. The status of human papilloma virus and tumor suppressor genes p53 and p16 in carcinomas of uterine cervix from India. Gynecol Oncol 1998;69:205-9.
13. INK4a binding domain of CDK4 in familial melanoma. Nature Genet 1996;12:97-9.
14. Nawroz H, Riet PVD, Hruban RH, Koch W, Ruppert JM, Sidransky D. Allelotype of head and neck squamous cell carcinoma. Cancer Res 1997;54:1152-5.
15. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual, 2nd edn, Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1989.
16. Heyman M, Rasool O, Brandter LB et al. Prognostic importance of p15INK4B and p16INK4A gene inactivation in childhood acute lymphocytic leukemia, J Clin Oncol 1996;14:1512-20.
17. Klangby BU, Okan I, Magnusson KP, Wendland M, Lind P, Wiman KG. P16/ INK4a and p15/INK4b gene methylation and absence of p16/INK4a mRNA and protein expression in Burkitt's lymphoma. Blood 1998;91:1680-7.
18. Liew CL, Li HM, Lo KW et al. High frequency of p16INK4A gene alterations in hepatocellular carcinoma, Oncogene 1999;18:789-95.
19. Dasgupta S, Mukherjee N, Roy S et al. Mapping of the candidate tumor suppressor genes' loci on human chromosome 3 in head and neck squamous cell carcinoma of Indian patient population. Oral Oncol 2002;38:6-15.
20. D'Costa J, Saranath D, Dedhia P, Sangvi V, Mehta AR. Detection of HPV-16 genome in human oral cancers and potentially malignant lesions from India. Oral Oncol 1998;34:413-20.
21. Park JS, Dong SM, Kim HS et al. Detection of p16 gene alteration in cervical cancer using tissue microdissection and LOH study. Cancer Lett 1999;136:101-8.
22. Balaram P, Nalinakumari KR, Abraham E et al. Human papilloma viruses in 91 oral cancers from Indian betel quid chewers - high prevalence and multiplicity of infections. Int J Cancer 1995;61:450-4.
23. Gillison ML, Koch WM, Capone RB et al. Evidence for a causal association between human papilloma virus and a subset of head and neck cancers. J Natl Cancer Inst 2000;92:709-20.
24. Nakashima R, Fujita M, Enomoto T et al. Alteration of p16 and p15 genes in human uterine tumors. Br J Cancer 1999;80:458-67.
25. Pollock PK, Pearson JV, Hayward NK. Compilation of somatic mutations of the CDKN2 gene in human cancers: non-random distribution of base substitutions. Genes Chromosomes Cancer 1996;15:77-88.
26. ink4) gene alterations in human ovarian tumors. Br J Cancer 1996;74:1069-73.
27. Kannan K, Munirajan AK, Krishnamurthy J et al. The p16INK4alpha/p19ARF gene mutations are infrequent and are mutually exclusive to p53 mutations in Indian oral squamous cell carcinomas. Int J Oncol 2000;16:585-90.
28. Muzeau F, Flejou JF, Thomas G, Hamelin R. Loss of heterozygosity on chromosome 9 and p16 (MTS1, CDKN2) gene mutations in esophageal cancers. Int J Cancer 1997;72:27-30.
29. Kim JR, Kim SY, Kim MJ, Kim JH. Alterations of CDKN2 (MTS1/p16INK4A) gene in paraffin-embedded tumor tissues of human stomach, lung, cervix and liver cancers. Exp Mol Med 1998;30:109-14.
30. Hirama T, Miller CW, Wilczynski SP, Koeffler HP. P16 (CDKN2A/cyclin-dependent-kinase-4 inhibitor/multiple tumor suppressor-1) gene is not altered in uterine cervical carcinomas or cell lines. Mod Pathol 1996;9:26-31.
31. Dong SM, Kim H-S, Rha S-H, Sidransky D. Promoter hypermethylation of multiple genes in carcinoma of uterine cervix. Clin Cancer Res 2001;7:1982-6.
32. Virmani AK, Mullar C, Rathi A, Zoechbauer-Muller S, Mathis M, Gazdar AF. Aberrant methylation during cervical carcinogenesis. Clin Cancer Res 2001;7:584-9.
33. Wong YF, Chung TKH, Cheung TH et al. Methylation of p16INK4A in primary gynecological malignancy. Cancer Lett 1999;136:231-5.
34. Cairns P, Polascik TJ, Eby Y et al. Frequency of homozygous deletion at pl6/CDKN2 in primary human tumors. Nature Genet 1995;11:210-2.